Quantcast CSL Wounded As Gardasil Sales Fall - Congoo
 
 
Log In
CSL wounded as Gardasil sales fall
Have an interest in this Story?
Sign Up for Real-Time email updates
WA Today.com.au  | July 23, 2008

Shares in drug company CSL have dived nearly 10% after Merck & Co, its licensing partner for cervical cancer vaccine Gardasil, wiped $US500 million off its expectations for full-year sales of the shot. Merck, which markets the vaccine and delivers royalties to CSL, said it was now expecting Gard...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Matthew Clark Matthew Clark
Mentor
Entrepreneur
Jay Byers Jay Byers
Owner
Healthcare General

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2008 Congoo.com. All Rights Reserved.